Molecular PsychiatryGenetic & Genomic MedicinePeer-reviewed journal article
DE NOVO VARIANTS IN THE POLY(RC)-BINDING PROTEIN GENE PCBP1 CAUSE A NEURODEVELOPMENTAL DISORDER
Wallid DebiD, Thomas BesnardiD, Florence Desprez, Benjamin CognéiD, Laura Do SoutoiD, Virginie VignardiD, Sylviane MarouillatiD, Louis JanueliD, Svetlana GorokhovaiD, Tiffany BusaiD, Victor Morel, Benjamin Dauriat, V. des PortesiD, Eyyüp ÜçtepeiD, Ozlem Akgun Dogan, Ahmet YeşilyurtiD, Yasemin AlanayiD, Anne Michele SlavotinekiD, Yu An, Hane LeeiD, Jessy Hary, Peter KannuiD, Taryn B. T. Athey, Ingrid M.B.H. van de LaariD, Marjon A. van Slegtenhorst, , Sébastien KüryiD
Abstract
Poly(rC)-binding protein 1 (PCBP1), a splicing factor and key member of the hnRNP E family, was initially characterized for its tumor suppressive properties. More recently, its role in regulating gene expression in the brain and nervous system has attracted growing interest. Through an international multicenter collaboration, we identified 13 de novo pathogenic variants in PCBP1 across 13 unrelated families. All affected individuals exhibited intellectual disability (ID), with autism spectrum disorder (ASD) as a prominent feature. Functional analysis in primary hippocampal mouse neuron cultures demonstrated that PCBP1 variants impair dendritic arborization, underscoring their deleterious effects. Transcriptomic profiling by RNA sequencing of subjects-derived T cells showed a distinctive signature characterized by significantly increased exon skipping. These results highlight the essential role of PCBP1 in neurogenesis and neuritogenesis, revealing the impact of loss-of-function variants in cells harboring PCBP1 pathogenic variants, thereby confirming the link between splicing defects and neurodevelopmental disorders. Collectively, our findings demonstrate the critical role of PCBP1 in neurodevelopment, reaffirming the importance of splicing regulation in mammalian neurodevelopment.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 31%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dominant-negative mutations in CBX1 cause a neurodevelopmental disorder
Yukiko Kuroda, Aiko Iwata‐Otsubo, … Kosuke Izumi·bioRxiv·Sep 29, 2020
- Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain
Felix Marbach, Georgi Stoyanov, … Elizabeth L. Fieg·Genetics in MedicinePeer-reviewed·Apr 8, 2021
- Molecular consequences of PQBP1 deficiency, involved in the X-linked Renpenning syndrome
Jérémie Courraud, Camille Engel, … Amélie Piton·Molecular PsychiatryPeer-reviewed·Nov 29, 2023
- Bi-allelic loss-of-function variants in PPFIBP1 cause a neurodevelopmental disorder with microcephaly, epilepsy and periventricular calcifications
Erik Rosenhahn, Thomas James O’Brien, … Konrad Platzer·The American Journal of Human GeneticsPeer-reviewed·Jul 12, 2022
- SETBP1 variants outside the degron disrupt DNA-binding and transcription independent of protein abundance to cause a heterogeneous neurodevelopmental disorder
Maggie M. K. Wong, Rosalie A. Kampen, … Simon E. Fisher·medRxiv·Mar 4, 2022
- Mapping PTBP splicing in human brain identifies targets for therapeutic splice switching including SYNGAP1
Jennine M. Dawicki-McKenna, Alex J. Félix, … Benjamin L. Prosser·Nature CommunicationsPeer-reviewed·May 6, 2023